Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUD HSCT for Pediatric Hematologic Malignancies
NCT00152139Phase 3Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2002
- Primary completion
- Jun 2005
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic hematopoietic stem cells in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), juvenile myelomonocytic leukemia (JMML), myelodysplastic syndrome (MDS), sponsored by St. Jude Children's Research Hospital. Started May 2002; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)chronic myeloid leukemia (CML)juvenile myelomonocytic leukemia (JMML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00152139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152139.